Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
YAM | has the stoping begun yet at coyote | 11/10/08 | 0 | 534 | |||
|
|||||||
YAM | asic goes after frost etc | 24/01/07 | 6 | 2.3K | |||
|
|||||||
YAM | somethings going on | 05/09/06 | 5 | 1.5K | |||
|
|||||||
YAM | mpj chomp chomp chomp 1.1 bid lol | 15/08/06 | 2 | 844 | |||
|
|||||||
YAM | mpj another 4mil chomp at 1.1 | 10/08/06 | 0 | 427 | |||
|
|||||||
YAM | mpj 4mil buyer at 1.1 prop or not | 10/08/06 | 1 | 693 | |||
|
|||||||
YAM | mpj now 20mil at 1vs 14mil at 1.1 | 09/08/06 | 1 | 669 | |||
|
|||||||
YAM | looks good 15mil bidding at .01 | 09/08/06 | 2 | 764 | |||
|
See All Discussions